Increased chemokine (C-C motif) ligand 21 expression and its correlation with osteopontin in Graves' disease

Endocrine
Yicheng QiShu Wang

Abstract

Graves' disease (GD) is a chronic autoimmune process characterized by the production of auto-antibodies that presumably consequent to the lymphocytic infiltrates in the thyroid. Chemokine (C-C motif) ligand 21 (CCL21) is important for the circulation of CC-chemokine receptor 7 (CCR7)-expressing cells. Meanwhile, osteopontin (OPN) enhances the production of proinflammatory cytokines and chemokines through NF-κB and MAPK signaling pathways in GD. Although CCL21 has been reported to play a vital role in several autoimmune diseases, little is known about the relationship between CCL21 and GD development. This study aimed to detect the CCL21 level in GD and to examine the role of OPN in regulating CCL21 production. 40 initial GD patients, 15 euthyroid GD patients, 12 TRAb-negative GD patients, and 25 healthy control donors were recruited. CCL21 levels in plasma and culture supernatants were quantified by enzyme-linked immunosorbent assay (ELISA). CD4+ T cells were isolated from peripheral blood mononuclear cells using antibody-coated magnetic beads. Quantitative polymerase chain reaction was used to determine CCL21 expression levels in CD4+ T cells. We demonstrated for the first time that plasma CCL21 levels were overexpressed in GD...Continue Reading

References

Jan 27, 1999·The Journal of Clinical Endocrinology and Metabolism·S CostagliolaK H Usadel
Nov 7, 2001·The Journal of Clinical Investigation·B Rapoport, S M McLachlan
Jul 10, 2003·Autoimmunity Reviews·Glinda S Cooper, Berrit C Stroehla
Oct 8, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrea P MartinSergio A Lira
Oct 12, 2004·Clinical Endocrinology·A P Weetman
Nov 18, 2004·Immunological Reviews·Kirsten SchneiderCarl F Ware
Mar 12, 2005·The Journal of Clinical Investigation·Guangwu XuJingwu Z Zhang
May 4, 2007·Endocrine Reviews·Mario RotondiPaola Romagnani
Apr 2, 2008·Nature Reviews. Immunology·Reinhold FörsterAntal Rot
Apr 17, 2008·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J DombergM Schott
Oct 28, 2008·Cytokine & Growth Factor Reviews·Kathryn X Wang, David T Denhardt
Nov 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gopal MurugaiyanHoward L Weiner
Jul 25, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Taku KuwabaraTerutaka Kakiuchi
Nov 26, 2009·The Journal of Allergy and Clinical Immunology·Scott P ComminsJohn W Steinke
Mar 1, 2008·Expert Review of Clinical Immunology·Nobuyuki Takasu, Jaeduk Yoshimura Noh
Jan 13, 2011·Arthritis and Rheumatism·Sarah R PickensShiva Shahrara
Sep 9, 2011·The Journal of Clinical Endocrinology and Metabolism·Lingyan XuShu Wang
Mar 7, 2012·Arthritis and Rheumatism·Sarah R PickensShiva Shahrara
May 31, 2012·Endocrine·Donald S A McLeod, David S Cooper
Apr 27, 2013·Clinical Endocrinology·Yicheng QiShu Wang
Nov 6, 2013·Autoimmunity Reviews·Alessandro AntonelliPoupak Fallahi
Jan 16, 2014·Autoimmunity Reviews·Francesca MenconiMichele Marinò

❮ Previous
Next ❯

Citations

Dec 28, 2018·European Journal of Clinical Investigation·Chao-Wen ChengJiunn-Diann Lin
Aug 16, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mohammad JafarnejadJames E Moore
Feb 16, 2020·Best Practice & Research. Clinical Endocrinology & Metabolism·Alessandro AntonelliSilvia Martina Ferrari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.